Clinical Trial Update: Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of a 4% hydroquinone cream for facial melasma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Melasma

Drugs mentioned

• Hydroquinone 4% cream (hydroquinone)

Snippet

Sponsor: Mesoestetic Pharma Group S.L. | Conditions: Facial Melasma | Phase 3 | Status: COMPLETED